FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Panel to Review OTC Meds for Upset Stomach/Hangovers

Federal Register Notice: FDA announces a 4/4 advisory committee meeting to discuss over-the-counter analgesic combination products used for upset stom...

Human Drugs

Priority Review Voucher Awarded to Biogen

FDA awards Biogen a priority review voucher (PRV)for gaining approval of rare disease drug Spinraza (nusinersen), indicated for treating spinal muscul...

Human Drugs

FDA Approves Serenity NDA for Night Urination

FDA approves a Serenity Pharmaceuticals NDA for Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urina...

Human Drugs

Lupin Gains Approval for Generic Suprep Bowel Prep

FDA approves a Lupin Ltd. ANDA for a generic copy of Braintree Laboratories Suprep Bowel prep kit.

FDA General

FDA is at Risk in Trump Budget: Alliance

Alliance for a Stronger FDA deputy executive director Steven Grossman says the agency is at risk in the coming Trump Administration budget request and...

Human Drugs

FDA Approves Merck Dust Mite Allergy Therapy

FDA approves Merck, Sharp & Dohmes Odactra, the first allergen extract to be administered under the tongue (sublingually) to treat house dust mite-ind...

Human Drugs

Court Dismisses Genentech Biosimilar Suit Against Amgen

A Delaware federal judge dismisses Genentechs BPCIA suit alleging Amgen failed to meet terms of the BPCIA in its application for a biosimilar Avastin....

Human Drugs

Companies Use Petitions to Delay Generics: Study

A University of California Institute for Innovation Law study indicates that drug companies are increasingly using the citizen petition process in an ...

Medical Devices

FDA Clears Neocis Dental Implant Robot Guidance

FDA clears a Neocis Inc. 510(k) for Yomi, a robotic guidance system for dental implant procedures.

Human Drugs

Juno Scraps CAR-T Cell Product Development

Juno Therapeutics halts development of its CAR-T cell product candidate JCAR015, indicated for relapsed or refractory B cell acute lymphoblastic leuke...